Evidence map›Paper›PMID 26812214›Full record

ArticleEmerging infectious diseases2016

Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013.

Claire von Mollendorf, Cheryl Cohen, Stefano Tempia, Susan Meiring, Linda de Gouveia, Vanessa Quan, Sarona Lengana, Alan Karstaedt, Halima Dawood, Sharona Seetharam and 5 more

Abstract readHistorical Article
In one paragraph

Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antimicrobial Drug Resistance inFrontiers in veterinary science · 2020
    Article
  10. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Claire von Mollendorf
Cheryl Cohen
Stefano Tempia
Susan Meiring
Linda de Gouveia
Vanessa Quan
Sarona Lengana
Alan Karstaedt
Halima Dawood
Sharona Seetharam
Ruth Lekalakala
Shabir A Madhi
Keith P Klugman
Anne von Gottberg
Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA)

Funding

PS08-868, S. Africa: EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTEU2GPS001328 · PS · NATIONAL HEALTH LABORATORY SERVICE · PI VAN HEERDEN, DR. JOHAN · 2008 to 2012
$44.4M
NCHHSTP CDC HHS U2G PS001328PHS HHS 5U2GPS001328
6 · The paper itself

Abstract

In South Africa, 7-valent pneumococcal conjugate vaccine (PCV) was introduced in April 2009 and replaced with 13-valent PCV in April 2011. We describe the epidemiology of serotype 1 Streptococcus pneumoniae disease during the pre- and post-PCV eras (2003-2013). Using laboratory-based invasive pneumococcal disease (IPD) surveillance, we calculated annual incidences, identified IPD clusters, and determined serotype 1-associated factors. Of 46,483 IPD cases, 4,544 (10%) were caused by serotype 1. Two clusters of serotype 1 infection were detected during 2003-2004 and 2008-2012, but incidence decreased after 2011. Among children <5 years of age, those who had non-serotype 1 IPD had shorter hospital stays, fewer cases of penicillin-nonsusceptible disease, and lower HIV prevalence and in-hospital death rates than did those with serotype 1 IPD; similar factors were noted for older patients. Serotype 1 IPD had distinctive clinical features in South Africa, and annual incidences fluctuated, with decreases noted after the introduction of PCV13.

Indexed as

AdolescentAdultAgedChildChild, PreschoolHistory, 21st CenturyHospitalizationHumansIncidenceInfantInfant, NewbornMiddle AgedMortalityOdds RatioPneumococcal InfectionsPneumococcal Vaccines13-valent pneumococcal vaccinePneumococcal VaccinesbacteremiaepidemiologyimmunizationincidenceinvasivePCV13pneumococcal conjugate vaccinepneumoniaserotype 1South AfricastreptococciStreptococcus pneumoniaesurveillancevaccination

Identifiers

PMID26812214
PMCPMC4734528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.